Intrinsic Edge Capital Management’s Teladoc Health TDOC Stock Holding History

Intrinsic Edge Capital Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-25,570	Closed	-$4.65M	–	277
2021 Q1	$4.65M	Buy	25,570 +9,562	+60%	+$2.22M	0.32%	114
2020 Q4	$3.2M	Hold	16,008	–	–	0.24%	142
2020 Q3	$3.51M	Sell	16,008 -6,359	-28%	-$1.35M	0.24%	145
2020 Q2	$4.27M	Sell	22,367 -38,665	-63%	-$6.78M	0.39%	100
2020 Q1	$9.46M	Buy	+61,032	New	+$7.1M	1.25%	20

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Intrinsic Edge Capital Management's TDOC Position: Q2 2021 in Review

Intrinsic Edge Capital Management sold out of Teladoc Health (TDOC) in Q2 2021, closing a stake of 25,570 shares — an estimated $4.65M sold.

Intrinsic Edge Capital Management first reported a position in TDOC in Q1 2020 and held it in 5 quarters. The position peaked at $9.46M in Q1 2020. 829 funds tracked by Wall St. Rank hold TDOC as of Q2 2021.

Intrinsic Edge Capital Management reported no remaining Teladoc Health position as of Q2 2021 after selling out during the quarter.
Intrinsic Edge Capital Management sold 25,570 Teladoc Health shares in Q2 2021, an estimated $4.65M.
Intrinsic Edge Capital Management first reported a position in Teladoc Health in Q1 2020 and held it in 5 quarters.
Intrinsic Edge Capital Management's Teladoc Health position peaked at $9.46M in Q1 2020.
829 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2021.

Based on Intrinsic Edge Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.